Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Eur J Med Chem. 2018 Oct 15;161:192–204. doi: 10.1016/j.ejmech.2018.10.020

Fig. 1. Schematic diagram illustrating an integrated systems pharmacology framework for predicting new associations of approved drugs and natural products on coronary artery disease (CAD).

Fig. 1.

(A) Construction of drug-target (compound-protein) networks for both approved drugs and natural products. (B) Building a protein-protein interaction (PPI) network for CAD proteins. (C) Predicting new associations of approved drugs and natural products on CAD via in silico models (see Methods).